Carlsbad-Encinitas Podiatry is categorized under Podiatrists in Carlsbad, CA and active since 1995.
Carlsbad-Encinitas Podiatry was established in 1995, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Podiatrists business, which does work in the B2C market, and is classified as a Podiatrists, under code number 6213910 by the NAICS.
If you are seeking more information, feel free to contact Ronald Lieberman, Owner at the company’s single location by writing to 3039 Jefferson St # G, Carlsbad, California CA 92008 or by phoning (760) 434-1270. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Carlsbad-Encinitas Podiatry |
Contact Person: | Ronald Lieberman, Owner |
Address: | 3039 Jefferson St # G, Carlsbad, California 92008 |
Phone Number: | (760) 434-1270 |
Website Address: | drronlieberman.com |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1995 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Podiatrists |
SIC Code: | 8043 |
NAICS Code: | 6213910 |
Share This Business: |
Carlsbad-Encinitas Podiatry was started in 1995 to provide professional Podiatrists under the SIC code 8043 and NAICS code 6213910. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Ronald Lieberman, Owner for inquiries that concern Carlsbad-Encinitas Podiatry by calling the company number (760) 434-1270, as your correspondence is most welcome. Additionally, the physical location of the single location of Carlsbad-Encinitas Podiatry can be found at the coordinates 33.16084,-117.34528 as well as the street address 3039 Jefferson St # G in Carlsbad, California 92008.
For its online presence, you may visit Carlsbad-Encinitas Podiatry’s website at drronlieberman.com and engage with its social media outlets through on Twitter and on Facebook.